ALZpath’s pTau217 antibody was released in 2023 and continues to be a key focus in Alzheimer’s disease research and ...

Zervimesine’s impact on debilitating DLB behavioral symptoms highlighted in podium presentation -- Plasma p-tau217 levels can identify Alzheimer’s patients most likely to benefit from zervimesine ...

A new study from Karolinska Institutet in Sweden suggests that people with dementia who also develop inflammatory bowel ...

The therapies, which are just starting to enter clinical trials, will need to prove clear clinical and quality-of-life ...

Dementia is a group of diseases that involve having trouble with memory, thinking, reasoning and other brain functions. It is ...

Live stream all the action from India's tour of England without spending anything.

, CWRU is Test Optional At the time of application, you choose whether you wish to apply with testing scores or as test-optional candidates, and you can change your mind about this up until two weeks ...